• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Introduction to 2-(4-fluorophenyl)piperidine hydrochloride (CAS No. 1187174-10-2)

2-(4-fluorophenyl)piperidine hydrochloride, identified by its Chemical Abstracts Service (CAS) number 1187174-10-2, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This compound belongs to the piperidine class of heterocyclic amines, characterized by a six-membered ring containing one nitrogen atom. The presence of a 4-fluorophenyl substituent on the piperidine ring introduces unique electronic and steric properties, making it a valuable scaffold for drug discovery and development.

The hydrochloride salt form of this compound enhances its solubility in aqueous solutions, which is a critical factor for formulation development in pharmaceutical applications. This solubility profile allows for easier administration and improved bioavailability, key considerations in the design of therapeutic agents.

In recent years, 2-(4-fluorophenyl)piperidine hydrochloride has garnered attention due to its potential applications in the treatment of various neurological and psychiatric disorders. The fluorine atom at the para position of the phenyl ring exerts a strong electron-withdrawing effect, influencing the compound's pharmacokinetic and pharmacodynamic properties. This modification is often employed to enhance binding affinity and metabolic stability, two crucial parameters in drug design.

One of the most compelling aspects of this compound is its role as a precursor in the synthesis of more complex pharmacological entities. Researchers have leveraged its structural framework to develop novel agents targeting neurotransmitter receptors, particularly those involved in mood regulation and cognitive function. The piperidine moiety is known for its ability to interact with central nervous system (CNS) receptors, while the fluorophenyl group provides additional modularity for fine-tuning biological activity.

Recent studies have highlighted the therapeutic potential of derivatives of 2-(4-fluorophenyl)piperidine hydrochloride in addressing conditions such as depression, anxiety, and schizophrenia. These investigations have revealed that modifications to the phenyl ring or the piperidine core can significantly alter receptor binding profiles, leading to improved efficacy or reduced side effects. For instance, analogs with varying degrees of fluorination have shown promise in preclinical models for their ability to modulate serotonergic and dopaminergic systems.

The synthesis of 2-(4-fluorophenyl)piperidine hydrochloride typically involves multi-step organic reactions, including nucleophilic substitution, cyclization, and salt formation. Advanced synthetic methodologies have been developed to optimize yield and purity, ensuring that pharmaceutical-grade material is obtained. Techniques such as palladium-catalyzed cross-coupling reactions have been particularly useful in constructing the desired fluorinated aromatic ring.

In addition to its neurological applications, this compound has shown promise in other therapeutic areas. Its structural motifs are reminiscent of known bioactive molecules, suggesting versatility in drug design. Researchers are exploring its potential in oncology, where targeted inhibition of specific signaling pathways is crucial for cancer treatment. The ability to fine-tune interactions with biological targets makes 2-(4-fluorophenyl)piperidine hydrochloride a versatile tool for medicinal chemists.

The pharmacological profile of 2-(4-fluorophenyl)piperidine hydrochloride is further influenced by its metabolic stability. The presence of the fluorine atom can impede oxidative degradation by enzymes such as cytochrome P450 (CYP450), extending the compound's half-life in vivo. This characteristic is particularly advantageous for drugs requiring prolonged action or multiple daily dosing regimens.

Regulatory considerations also play a significant role in the development and commercialization of compounds like 2-(4-fluorophenyl)piperidine hydrochloride. Compliance with Good Manufacturing Practices (GMP) ensures that pharmaceutical products meet stringent quality standards before reaching clinical use. Preclinical safety studies are conducted to assess toxicity profiles and identify potential adverse effects, providing critical data for regulatory submissions.

The future direction of research on 2-(4-fluorophenyl)piperidine hydrochloride lies in expanding its therapeutic applications through structure-activity relationship (SAR) studies. By systematically varying substituents on the piperidine or phenyl rings, researchers aim to uncover new mechanisms of action or improve existing ones. Computational modeling techniques are increasingly employed to predict biological activity and guide synthetic efforts toward high-value candidates.

Collaborative efforts between academic institutions and pharmaceutical companies are essential for advancing the development of novel therapeutics based on this compound. Such partnerships facilitate knowledge exchange and resource sharing, accelerating progress toward clinical translation. The integration of cutting-edge technologies like high-throughput screening (HTS) and artificial intelligence (AI)-assisted drug design is expected to further enhance discovery pipelines.

In conclusion, 2-(4-fluorophenyl)piperidine hydrochloride represents a promising entity in modern drug discovery with diverse applications across neurological and oncological therapies. Its unique structural features offer opportunities for designing next-generation pharmaceuticals with improved efficacy and safety profiles. Continued research efforts will likely uncover new insights into its potential benefits while refining synthetic methodologies for scalable production.

• 1228542-46-8((S)-2-(3-Fluorophenyl)piperidine)
• 383128-03-8(2-(4-Fluorophenyl)piperidine)
• 1073556-40-7((S)-2-(4-Fluorophenyl)pyrrolidine hydrochloride)
• 168890-44-6(2-(4-Fluorophenyl)azepane)
• 1185310-00-2([1-(4-Fluoro-phenyl)-ethyl]-piperidin-4-yl-amine hydrochloride)
• 1187173-24-5(2-(3-Fluorophenyl)piperidine hydrochloride)
• 1381928-30-8((2R)-2-(4-fluorophenyl)pyrrolidine hydrochloride)
• 1187468-22-9((2S)-2-(4-fluorophenyl)piperidine)
• 1187468-21-8((2R)-2-(4-fluorophenyl)piperidine)
• 383128-42-5(2-(3-Fluorophenyl)piperidine)